Polymyxin B-Induced Skin Hyperpigmentation-Reference-Cited by-同舟云学术

Polymyxin B-Induced Skin Hyperpigmentation

Published:2020-09-18 Issue: Volume:2020 Page:1-3
ISSN:1687-9627
Container-title:Case Reports in Medicine
language:en
Short-container-title:Case Reports in Medicine

Author:

Wen Xueke¹,Luo Chunliu²^ORCID,Lyu Weitao²

Affiliation:

1. The First Clinical Medical College of Jinan University, No. 601 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, China

2. The First Affiliated Hospital of Jinan University, No. 613 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, China

Abstract

Polymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR). In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed. The patient was treated with polymyxin B and subsequently developed skin hyperpigmentation and desquamation. The desquamation improved and the pigmentation gradually returned to normal after sixty days after the withdrawal of polymyxin B.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://downloads.hindawi.com/journals/crim/2020/6461329.pdf

Reference12 articles.

1. Polymyxin B Induced Generalized Hyperpigmentation in Neonates

2. Colistin neurotoxicity: revisited

3. Polymyxins Revisited

4. Polymyxin B induced generalized skin hyperpigmentation in infants

5. Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Pigmentation: A Review;Drugs;2024-08-01

2. Vibrational and DFT analysis of Kojic acid-Pyridoxine biomolecular complex;Journal of Molecular Structure;2024-01

3. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study;Annals of Translational Medicine;2022-10

4. Mucus-permeable polymyxin B-hyaluronic acid/ poly (lactic-co-glycolic acid) nanoparticle platform for the nebulized treatment of lung infections;Journal of Colloid and Interface Science;2022-10

5. Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis;Microbiology Spectrum;2022-04-27